A Caesars World stockholder group brought a...

A Caesars World stockholder group brought a class-action suit against directors of the Los Angeles-based casino operator, alleging that they breached their fiduciary duty by adopting an anti-takeover measure. The suit, in U.S. District Court in Los Angeles, said the so-called poison pill was aimed at preventing any acquisition of the company. The suit said several friendly suitors have approached the company with offers “far in excess” of the current market price of Caesars’ stock, $31.375, and noted that New York financier Donald J. Trump has obtained federal clearance to acquire 15% of the company’s shares.